Search results for #adjuvant
🎧 Catch the latest @Uromigos (@brian_rini, @tompowles1) episode with @AlisonBirtle on the use of #adjuvant #chemotherapy after #nephroureterectomy for patients with #UTUC. 👂 Listen Now: buff.ly/3y8uz03
📢#MarkUrCalendars! @myESMO #VirtualPlenary for May 2024: Results from randomized study of 6yrs vs. 3yrs of #adjuvant #imatinib in #highrisk #GISTs presented by @jeanyvesblay. Expert commentaries by #internationalexperts from #US/#Europe & #AsiaPacific. Don't miss this!…
📖 Prof. Timothy M. Pawlik's team published the article “Emerging data on immune checkpoint inhibitors in the #neoadjuvant and #adjuvant setting for patients with #HCC” recently. @timpawlik ✏ Read more: f.oaes.cc/xmlpdf/98d1eee…
Adding a compatibility #adjuvant to your tank-mix can help speed up the operation & prevent mixing problems. 🌧️ With weather conditions forcing growers to put bigger, more complex mixes in tanks, read how careful preparation is key to avoiding disasters bit.ly/3PZhNHx
While many #vaccines rely on tried-and-true aluminum adjuvants, Chinese developers are now working on their own novel #adjuvant tech. Though late to the game, these can help enhance vaccine efficiency beyond traditional options. #WorldImmunizationWeek datawrapper.de/_/Rkjmc/
✨ The role of #DNAsensing in alum #adjuvant activity ✨ Delve into this review from @UofGSii researchers to gain a clearer understanding of how this adjuvant works, how it can inform #VaccineDesign & outstanding questions this #WorldImmunizationWeek ➡️bit.ly/3Ywhk1E
#Adsorption Capabilities of Fungoid #Chitosan Toward Organic Acids in Model Solutions and White #Wine doi.org/10.1007/s11947… #Tartaric acid #Titratable acidity #Adjuvant @distal_unibo @Unibo
Did you hear about the #FDA approval of #alectinib for #adjuvant treatment of #ALK-positive non–small cell #lung cancer (#NSCLC)? Comment your thoughts below and read additional perspectives on the trial from Dr. Morana Vojnic (@Moranaaa) here! oncdata.com/news/alectinib… #lcsm
Pulse crops are extremely sensitive to #weed competition in the early stages, so it's worth considering a pre-em + #adjuvant Backrow Max to get crops off to the best start. 👌 Learn more ➡️ bit.ly/3W20WaK
🎙️ In episode 309 of the @Uromigos, @brian_rini and @tompowles1 talk with @MattGalsky about the #OS signal data from #CheckMate274, which analyzed the use of #adjuvant #nivolumab in patients with #MIBC. 👉 Listen Here: buff.ly/3JioJM6
You don’t raise baby pigs in a pasture, so why would you give them a vaccine targeting cows? Precision Select adjuvants help vets create a more targeted product. Learn more: hubs.la/Q02q-1TH0 #autongeous #vaccines #veterinarians #custom #animalhealth #adjuvant
#FDA #approves #alectinib as #adjuvant treatment for ALK-positive non-small cell #lungcancer Efficacy demonstrated in #global, #randomized, open-label ALINA trial in #ALK-positive #NSCLC who had complete #tumor #resection. fda.gov/drugs/resource… #Oncology #Oncologyresearch…
Since we know beyond #AnyShadowOfADoubt that #Vaccines are sometimes more #dangerous than the #diseases they are supposed to prevent, why is the word #AntiVaxer considered a #pejorative? To those people who attack #AndrewWakefield: Do you know what an #Adjuvant is you #cretins?
🔥🚨@OncoAlert HOT OFF THE PRESS BIG NEWS @US_FDA approves #Adjuvant #Alectinib following surgery in patients with stage IB-IIIA #ALK+Non-Small Cell #LungCancer based on results of #Alina trial: ⬆️#DFS HR: 0.24 (compared with adjuvant chemotherapy). 👇🏼 fda.gov/drugs/resource…
🔥🚨@OncoAlert HOT OFF THE PRESS BIG NEWS @US_FDA approves #Adjuvant #Alectinib following surgery in patients with stage IB-IIIA #ALK+Non-Small Cell #LungCancer based on results of #Alina trial: ⬆️#DFS HR: 0.24 (compared with adjuvant chemotherapy). 👇🏼 fda.gov/drugs/resource… https://t.co/w2KyIqLMFT
💡 Catch our discussion with @MattGalsky of @IcahnMountSinai on the first #OS update from the #CheckMate 274 trial on #adjuvant #nivolumab for patients with high-risk #MIBC. 📺 Watch Now: buff.ly/3QaAmIN
👀 #ICYMI: @DrChoueiri and colleagues reported long-term results from the #KEYNOTE564 study showing #OS improvement in patients with #ccRCC who received #adjuvant #pembrolizumab. 🧠 Learn More: buff.ly/42pWPq3
#OverallSurvival with #Adjuvant #Pembrolizumab in #Renal-#Cell #Carcinoma A significant improvement in overall survival with pembrolizumab vs placebo (HR, 0.62; P=0.005). The estimated OS at 48 months = 91.2% in the pembrolizumab group vs 86.0% in placebo group. #NEJM…
Overall #Survival with #Adjuvant #Pembrolizumab in #RenalCell #Carcinoma | New England Journal of Medicine nejm.org/doi/full/10.10…
Self-adjuvanting polymeric nanovaccines enhance IFN production and cytotoxic T cell response. | Xun Sun @SCUCN | [50 days' free access] #nanocapsule #SubunitVaccine #adjuvant authors.elsevier.com/a/1iv5BcI2-5wdS